Patent application number | Description | Published |
20090276642 | VOLTAGE REGULATOR WITH SUSPEND MODE - A system is disclosed. The system includes a central processing unit (CPU) to operate in one or more low power sleep states, and a power converter. The power converter includes phase inductors; and one or more power switches to drive the phase inductors. The one or more power switches are deactivated during the CPU sleep state. | 11-05-2009 |
20090313489 | INDEPENDENT POWER CONTROL OF PROCESSING CORES - Independent power control of two or more processing cores. More particularly, at least one embodiment of the invention pertains to a technique to place at least one processing core in a power state without coordinating with the power state of one or more other processing cores. | 12-17-2009 |
20100174936 | Communicating Via An In-Die Interconnect - In one embodiment, the present invention includes a method for writing data from a writer coupled to a reader via an in-die interconnect into a queue entry according to a first clock of the writer, generating a mapping of which second clocks of the reader that the reader is allowed to read from the queue, based at least in part on the first and second clocks, and reading the data from the entry at an allowed second clock. Other embodiments are described and claimed. | 07-08-2010 |
20110022865 | INDEPENDENT POWER CONTROL OF PROCESSING CORES - Independent power control of two or more processing cores. More particularly, at least one embodiment of the invention pertains to a technique to place at least one processing core in a power state without coordinating with the power state of one or more other processing cores. | 01-27-2011 |
20110191607 | INDEPENDENT POWER CONTROL OF PROCESSING CORES - Independent power control of two or more processing cores. More particularly, at least one embodiment of the invention pertains to a technique to place at least one processing core in a power state without coordinating with the power state of one or more other processing cores. | 08-04-2011 |
20120226926 | INDEPENDENT POWER CONTROL OF PROCESSING CORES - Independent power control of two or more processing cores. More particularly, at least one embodiment of the invention pertains to a technique to place at least one processing core in a power state without coordinating with the power state of one or more other processing cores. | 09-06-2012 |
20120239946 | Independent Power Control of Processing Cores - Independent power control of two or more processing cores. More particularly, at least one embodiment of the invention pertains to a technique to place at least one processing core in a power state without coordinating with the power state of one or more other processing cores. | 09-20-2012 |
Patent application number | Description | Published |
20090063594 | COMPUTER SYSTEM MEMORY MANAGEMENT - The number of CPU cycles required to reclaim object memory space in a memory management process is reduced by using a two phase approach. A data structure exists for each object that is to be loaded into object memory space. One part of the data structure is the object definition. The other part is a MM (Memory Management) immunity annotation or value that controls the frequency with which the object must actually be examined to determine if it is suitable for reclamation. On each iteration of the memory management process, the object's MM immunity value is tested to determine whether it is greater than a predetermined threshold. If greater than the threshold, the value is decremented, but the object is not actually examined for its suitability for removal. If the value equals the threshold, the object itself is examined. If it is found to be suitable, it is removed to reclaim the object memory space it previously occupied, If it is actually examined but is found not to be suitable for removal, the MM immunity value is reset to its original value or is otherwise adjusted to prevent examination of the object for a certain number of future iterations of the memory management process. | 03-05-2009 |
20090122704 | Limiting Extreme Loads At Session Servers - A method, system and computer program product for limiting extreme loads and reducing fluctuations in load at session servers. An admission rate controller of a SIP router calculates the “deflator ratio” equal to the average number of in-dialog messages received over a first fixed interval of time divided by the average number of out-of-dialog messages received over a second fixed interval of time. Further, the admission rate controller calculates the “dampening ratio” equal to the maximum number of messages allowed over a period of time divided by the number of messages admitted over a previous time interval. When an overload condition has been detected, the admission rate controller calculates the maximum number of out-of-dialog messages to be sent to its associated SIP server based on the deflator and dampening ratios. In this manner, a smoother transition from the overload condition to the non-overload condition may occur. | 05-14-2009 |
20090122705 | Managing Bursts of Traffic In Such a Manner as to Improve The Effective Utilization of Session Servers - A method, system and computer program product for managing bursts of traffic. A counter, referred to herein as a “frequency counter,” is incremented during those time intervals an overload condition is detected and is decremented during those time intervals an overload condition is not detected. An overload condition may refer to when the number of out-of-dialog messages exceeds a threshold value corresponding to the maximum number of out-of-dialog messages that should be accepted and forwarded to an associated session server. If the count of the frequency counter exceeds some pre-configured value, then traffic that exceeds the threshold for the overload condition is stopped from being sent to the associated session server. Otherwise, traffic that exceeds the threshold for the overload condition is permitted to be sent to the associated session server. By managing bursts of traffic in such a manner, the effective utilization of session servers is improved. | 05-14-2009 |
20090177779 | Methods and Apparatus for Randomization of Periodic Behavior in Communication Network - A technique for use in a client, wherein the client supports a state-based signaling protocol (e.g., Session Initiation Protocol or SIP), includes initiating a given session state between the client and a server that also supports the state-based signaling protocol, and refreshing the given session state in a randomized manner. Further, a technique for use in a server, wherein the server supports a state-based signaling protocol (again, e.g., SIP), includes randomly assigning an expiration time duration for a given session state between the server and a client that also supports the state-based signaling protocol, and reporting the randomly assigned expiration time for the given session state to the client. By randomizing various behaviors of the client, the server, or both, bursty traffic in the communication network is reduced or eliminated. | 07-09-2009 |
20110119367 | Methods and Apparatus for Randomization of Periodic Behavior in Communication Network - A technique for use in a client, wherein the client supports a state-based signaling protocol (e.g., Session Initiation Protocol or SIP), includes initiating a given session state between the client and a server that also supports the state-based signaling protocol, and refreshing the given session state in a randomized manner. Further, a technique for use in a server, wherein the server supports a state-based signaling protocol (again, e.g., SIP), includes randomly assigning an expiration time duration for a given session state between the server and a client that also supports the state-based signaling protocol, and reporting the randomly assigned expiration time for the given session state to the client. By randomizing various behaviors of the client, the server, or both, bursty traffic in the communication network is reduced or eliminated. | 05-19-2011 |
Patent application number | Description | Published |
20100331397 | 2-5A ANALOGS AND THEIR METHODS OF USE - Disclosed herein are compounds that activate RNaseL, methods of synthesizing compounds that activate RNaseL and the use of compounds that activate RNaseL for treating and/or ameliorating a disease or a condition, such as a viral infection, a bacterial infection, cancer and/or parasitic disease. | 12-30-2010 |
20120070415 | AZIDO NUCLEOSIDES AND NUCLEOTIDE ANALOGS - Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof. Examples of viral infections include a respiratory syncytial viral (RSV) and influenza infection. | 03-22-2012 |
20120071434 | SUBSTITUTED NUCLEOTIDE ANALOGS - Disclosed herein are phosphorothioate nucleotide analogs, methods of synthesizing phosphorothioate nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the phosphorothioate nucleotide analogs. | 03-22-2012 |
20120165286 | CYCLIC NUCLEOTIDE ANALOGS - Disclosed herein are cyclic nucleotide analogs, methods of synthesizing cyclic nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with cyclic nucleotide analogs. | 06-28-2012 |
20130165400 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF - Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof. | 06-27-2013 |
20140303108 | CYCLIC NUCLEOTIDE ANALOGS - Disclosed herein are cyclic nucleotide analogs, methods of synthesizing cyclic nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with cyclic nucleotide analogs. | 10-09-2014 |
20150038451 | SUBSTITUTED NUCLEOTIDE ANALOGS - Disclosed herein are phosphorothioate nucleotide analogs, methods of synthesizing phosphorothioate nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the phosphorothioate nucleotide analogs. | 02-05-2015 |
20150051167 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF - Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof. | 02-19-2015 |
20150105341 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF - Disclosed herein are nucleosides, nucleotides and nucleotide analogs, methods of synthesizing the same and methods of treating diseases and/or conditions such as a Picornavirus and/or Flaviviridae infection with one or more nucleosides, nucleotides and nucleotide analogs. | 04-16-2015 |
20150183819 | AZIDO NUCLEOSIDES AND NUCLEOTIDE ANALOGS - Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof. Examples of viral infections include a respiratory syncytial viral (RSV) and influenza infection. | 07-02-2015 |
Patent application number | Description | Published |
20120159457 | VALIDATING RUN-TIME REFERENCES - Identifying conflicting declared invalid runtime references of overlaid data structures of a shared memory area as declared in a program listing. The identifying includes identifying a first data structure and a first parameter list in the program listing. A first routine call and a sequential flow of execution of the first routine call through the program listing in order to write data to the shared memory area are identified. A second data structure and a second parameter list in the program listing are identified. A second routine call and a second sequential flow of execution of the second routine call through the program listing in order to write data to the shared memory area are identified. It is determined whether the second routine call is attempting to overwrite data of the first routine call with the data of the second routine call in the shared memory area. | 06-21-2012 |
20130185021 | Automated Performance Data Management and Collection - Performance data for a healthy system is captured and used to create benchmarks that represent behavior of the computing environment in a healthy state. Current behavior (e.g, run-time characteristics) of the computing environment are monitored in an on-going manner, and are compared to the benchmarks. When a benchmark is violated, performance data capture is dynamically and automatically enabled. Or, if performance data is already being captured, then performance data capture may be enabled for a larger subset of possible data. Optionally, performance data capture may be automatically disabled upon detecting that the current behavior of the computing environment has returned to a healthy state where benchmarks are no longer violated. | 07-18-2013 |
20130226526 | Automated Performance Data Management and Collection - Performance data for a healthy system is captured and used to create benchmarks that represent behavior of the computing environment in a healthy state. Current behavior (e.g, run-time characteristics) of the computing environment are monitored in an on-going manner, and are compared to the benchmarks. When a benchmark is violated, performance data capture is dynamically and automatically enabled. Or, if performance data is already being captured, then performance data capture may be enabled for a larger subset of possible data. Optionally, performance data capture may be automatically disabled upon detecting that the current behavior of the computing environment has returned to a healthy state where benchmarks are no longer violated. | 08-29-2013 |